...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Inventory and Revenue calcs

Masila,

Sales of any sort would mean this has been emergency approved to treat covid (somewhere in the world) and would probably send this price through the roof on speculation and hype alone.

However, I would also point out that DM said the 600kg of product currently warehoused will be significantly more expensive than $6.85/pill. He mentioned $800/month for treatment at this time (roughly $13.40/pill).

The $6.85/pill would be the cost after economy of scale is realized through mass production.

Regardless, covid emergency approval is instant credibility and skyrocketed share price, IMO.

Share
New Message
Please login to post a reply